|
1
|
Committee GE: Global strategy for the
diagnosis, management, and prevention of chronic obstructive
pulmonary disease. Revised. 2011.
|
|
2
|
Incalzi RA, Caradonna P, Ranieri P, Basso
S, Fuso L, Pagano F, Ciappi G and Pistelli R: Correlates of
osteoporosis in chronic obstructive pulmonary disease. Respir Med.
94:1079–1084. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Katsura H and Kida K: A comparison of bone
mineral density in elderly female patients with COPD and bronchial
asthma. Chest. 122:1949–1955. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bon J, Fuhrman CR, Weissfeld JL, Duncan
SR, Branch RA, Chang CC, Zhang Y, Leader JK, Gur D, Greenspan SL
and Sciurba FC: Radiographic emphysema predicts low bone mineral
density in a tobacco-exposed cohort. Am J Respir Crit Care Med.
183:885–890. 2011. View Article : Google Scholar :
|
|
5
|
Lehouck A, Boonen S, Decramer M and
Janssens W: COPD, bone metabolism, and osteoporosis. Chest.
139:648–657. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boyce BF and Xing L: The RANKL/RANK/OPG
pathway. Curr Osteoporos Rep. 5:98–104. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lacey DL, Timms E, Tan HL, Kelley MJ,
Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S,
et al: Osteoprotegerin ligand is a cytokine that regulates
osteoclast differentiation and activation. Cell. 93:165–176. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Väänänen HK and Laitala-Leinonen T:
Osteoclast lineage and function. Arch Biochem Biophys. 473:132–138.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bai P, Sun Y, Jin J, Hou J, Li R, Zhang Q
and Wang Y: Disturbance of the OPG/RANK/RANKL pathway and systemic
inflammation in COPD patients with emphysema and osteoporosis.
Respir Res. 12:1572011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pobeha P, Petrasova D, Tkacova R and Joppa
P: Circulatory osteoprotegerin is related to osteoporosis of the
hip in patients with COPD. Respir Med. 108:621–627. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rifas L, Arackal S and Weitzmann MN:
Inflammatory T cells rapidly induce differentiation of human bone
marrow stromal cells into mature osteoblasts. J Cell Biochem.
88:650–659. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kong YY, Feige U, Sarosi I, Bolon B,
Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, et al:
Activated T cells regulate bone loss and joint destruction in
adjuvant arthritis through osteoprotegerin ligand. Nature.
402:304–309. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kotake S, Udagawa N, Hakoda M, Mogi M,
Yano K, Tsuda E, Takahashi K, Furuya T, Ishiyama S, Kim KJ, et al:
Activated human T cells directly induce osteoclastogenesis from
human monocytes: Possible role of T cells in bone destruction in
rheumatoid arthritis patients. Arthritis Rheum. 44:1003–1012. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miranda-Carús ME, Benito-Miguel M, Balsa
A, Cobo-Ibáñez T, Pérez de Ayala C, Pascual-Salcedo D and
Martín-Mola E: Peripheral blood T lymphocytes from patients with
early rheumatoid arthritis express RANKL and interleukin-15 on the
cell surface and promote osteoclastogenesis in autologous
monocytes. Arthritis Rheum. 54:1151–1164. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sato K, Suematsu A, Okamoto K, Yamaguchi
A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y,
et al: Th17 functions as an osteoclastogenic helper T cell subset
that links T cell activation and bone destruction. J Exp Med.
203:2673–2682. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kikuta J, Wada Y, Kowada T, Wang Z,
Sun-Wada GH, Nishiyama I, Mizukami S, Maiya N, Yasuda H, Kumanogoh
A, et al: Dynamic visualization of RANKL and Th17-mediated
osteoclast function. J Clin Invest. 123:866–873. 2013.PubMed/NCBI
|
|
17
|
Sullivan AK, Simonian PL, Falta MT,
Mitchell JD, Cosgrove GP, Brown KK, Kotzin BL, Voelkel NF and
Fontenot AP: Oligoclonal CD4+ T cells in the lungs of
patients with severe emphysema. Am J Respir Crit Care Med.
172:590–596. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maeno T, Houghton AM, Quintero PA,
Grumelli S, Owen CA and Shapiro SD: CD8+ T cells are
required for inflammation and destruction in cigarette
smoke-induced emphysema in mice. J Immunol. 178:8090–8096. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Doe C, Bafadhel M, Siddiqui S, Desai D,
Mistry V, Rugman P, McCormick M, Woods J, May R, Sleeman MA, et al:
Expression of the T helper 17-associated cytokines IL-17A and
IL-17F in asthma and COPD. Chest. 138:1140–1147. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vestbo J, Hurd SS, Agustí AG, Jones PW,
Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ,
Nishimura M, et al: Global strategy for the diagnosis, management,
and prevention of chronic obstructive pulmonary disease: GOLD
executive summary. Am J Respir Crit Care Med. 187:347–365. 2013.
View Article : Google Scholar
|
|
21
|
Hou J, Sun Y, Hao Y, Zhuo J, Liu X, Bai P,
Han J, Zheng X and Zeng H: Imbalance between subpopulations of
regulatory T cells in COPD. Thorax. 68:1131–1139. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Oltmanns U, Chung KF, Walters M, John M
and Mitchell JA: Cigarette smoke induces IL-8, but inhibits eotaxin
and RANTES release from airway smooth muscle. Respir Res. 6:742005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brusselle GG, Joos GF and Bracke KR: New
insights into the immunology of chronic obstructive pulmonary
disease. Lancet. 378:1015–1026. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen K, Pociask DA, McAleer JP, Chan YR,
Alcorn JF, Kreindler JL, Keyser MR, Shapiro SD, Houghton AM, Kolls
JK and Zheng M: IL-17RA is required for CCL2 expression, macrophage
recruitment, and emphysema in response to cigarette smoke. PLoS
One. 6:e203332011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shan M, Yuan X, Song LZ, Roberts L,
Zarinkamar N, Seryshev A, Zhang Y, Hilsenbeck S, Chang SH, Dong C,
et al: Cigarette smoke induction of osteopontin (SPP1) mediates
T(H)17 inflammation in human and experimental emphysema. Sci Transl
Med. 4:117ra92012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eustace A, Smyth LJ, Mitchell L,
Williamson K, Plumb J and Singh D: Identification of cells
expressing IL-17A and IL-17F in the lungs of patients with COPD.
Chest. 139:1089–1100. 2011. View Article : Google Scholar
|
|
27
|
Zhang J, Chu S, Zhong X, Lao Q, He Z and
Liang Y: Increased expression of CD4+IL-17+
cells in the lung tissue of patients with stable chronic
obstructive pulmonary disease (COPD) and smokers. Int
Immunopharmacol. 15:58–66. 2013. View Article : Google Scholar
|
|
28
|
Majori M, Corradi M, Caminati A, Cacciani
G, Bertacco S and Pesci A: Predominant TH1 cytokine pattern in
peripheral blood from subjects with chronic obstructive pulmonary
disease. J Allergy Clin Immunol. 103:458–462. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vargas-Rojas MI, Ramírez-Venegas A,
Limón-Camacho L, Ochoa L, Hernández-Zenteno R and Sansores RH:
Increase of Th17 cells in peripheral blood of patients with chronic
obstructive pulmonary disease. Respir Med. 105:1648–1654. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Choi Y, Woo KM, Ko SH, Lee YJ, Park SJ,
Kim HM and Kwon BS: Osteoclastogenesis is enhanced by activated B
cells but suppressed by activated CD8(+) T cells. Eur J Immunol.
31:2179–2188. 2001. View Article : Google Scholar : PubMed/NCBI
|
